FormattedPicture
View from the Top: Knud Vindfeldt, Head of Cultures & Enzymes, Chr. Hansen

March 2013
--- Knud Vindfeldt: “Chr. Hansen has a clear strategy to obtain EU approved health claims for our core probiotic strains. While the EFSA demands are high and timelines have been challenging, this does not change our strategy. To protect our customers and consumers from conflicting messages, we will only submit our applications for health claims when we are confident we have sufficient data to meet the EFSA requirements.”
PortraitPicture

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

A new low-calorie sweetener made from mogrosides and galactooligosaccharides may offer the same effects as artificial sweeteners with none of the negative consequences... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As industry eyes the gut-brain axis and the potential of probiotics for leveraging a slew of health benefits, companies are spotlighting the opportunities of the... Read More

FormattedPicture

FOOD INGREDIENTS NEWS

Kerry’s financial results for the first half of the year saw a revenue increase of 13.3% to €4.1 billion (US$4.19 billion), representing 15.2% organic growth... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

As consumers and industry continue to explore the connection between the gut microbiome and its effect on mood, cognition and serotonin production, companies are... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Research by Morinaga Milk has unveiled the order in which Bifidobacterium species reach an infant’s gut has an impact on the way human milk oligosaccharides (HMOs)... Read More

trans